Nuclear medicine methods in the diagnosis of cardiovascular illnesses

1. Marcassa C, De­la­loye AB, Cuoco­lo A et al. The re­gu­la­to­ry background of nuclear cardio­lo­gy in Euro­pe: a survey by the Euro­pean Council of Nuclear Cardio­lo­gy. Eur J Nucl Med 2006; 33(12): 1509–1512.

2. Ada­mi­ko­va A, Ba­ka­la J, Berna­tek J, Ryb­ka J, Sva­ci­na S. Transient ische­mic di­ta­tion ra­tio(TID) corre­la­tes with HbA1c in pa­tients with dia­be­tes ty­pe 2 with pro­ven myocardial ische­mia according to exerci­se myocardial SPECT. Ann Nucl Med 2006; 20(9): 615–621.

3. Biagi­ni E, Shaw LJ, Poldermans D et al. Accu­ra­cy of non–inva­si­ve techni­ques for diagnostic of co­ro­na­ry arte­ry di­sea­se and pre­diction of cardiac events in pa­tients with left bundle branch bloch: a me­ta–ana­ly­sis. Eur J Nucl Med 2006; 33(12): 1442–1451.

4. Wiersma JJ, Verberne HJ, Trip MD et al. Pre­va­lence of myocardial ischae­mia as assessed with myocardial perfu­sion scintigraphy in pa­tients with dia­be­tes melli­tus ty­pe 2 and mild angi­nal symptoms. Eur J Nucl Med 2006; 33(12): 1468–1476.

5. Noble GL, Heller GV. Single–pho­ton Emission Compu­ted To­mography Myocardial Perfu­sion Imagnig in Pa­tients with Diabe­tic. Curr Cardiol Rep 2005; 7(2): 117–123.

6. Ra­ja­go­pa­lan N, Miller TD, Hodge DO et al. Identi­fying high–risk asympto­ma­tic diabe­tic pa­tients who are candi­da­tes for scree­ning stress single–pho­ton emission compu­ted to­mography ima­ging. J Am Coll Cardiol 2005; 45: 43–49.

7. Ritchie JL, Ba­te­man TM, Bo­now RO et al. ACC/AHA Task Force re­port Giude­li­nes for cli­ni­cal use of cardiac ra­dio­nucli­de ima­ging. Re­port of the Ame­ri­can Colle­ge of Cardio­lo­gy/Ame­ri­can Heart Asso­cia­tion Task Force on assessment of diagnostic and the­ra­peu­tic cardio­vascu­lar pro­ce­du­res (Committee on Ra­dio­nucli­de Ima­ging): de­ve­lo­ped in colla­bo­ra­tion with the Ame­ri­can So­cie­ty of Nuclear Cardio­lo­gy. J Am Coll Cardiol 1995; 25: 521–547.

8. Gokcel A, Aydin M, Yalcin F et al. Si­lent co­ro­na­ry arte­ry di­sea­se in pa­tients with ty­pe 2 dia­be­tes melli­tus. Acta Diabe­tol 2003; 40(4): 176–180.

9. Ba­soglu T, Coskun C, Bernay T et al. Myocardial perfu­sion SPECT ima­ging with Tc–99m–Tetro­fosmin in ty­pe II dia­be­tes melli­tus pa­tients: A compa­ri­son to Tl–201 SPECT, pre­li­mi­na­ry re­sults. Eur J Nucl Med 1996; 23(9): 1027–1028. EANM Co­penha­gen Poster Pre­senta­tion.

10. Abdulna­bi T, Ma­hussain SA, Sa­da­nandan S. Cardiac tests in asympto­ma­tic ty­pe diabe­tics. Med Princ Prac 2002; 11(4): 171–175.

11. Trea­se L, van Eve­ry B, Bennel K et al. A prospecti­ve blinded eva­lua­tion of exerci­se thallium–201 SPET in pa­tients with suspected chro­nic exertio­nal compartment syndro­me of the leg. Eur J Nucl Med 2001; 28(6): 688–695.

12. Cerquei­ra MD. Myocardial Perfu­sion Ima­ging: Ro­le in Progno­sis, Fu­tu­re Appli­ca­tions. http://www.medsca­pe.com/viewprogram/1806.

13. Abi­dov A, Berman D. Transient ische­mic di­la­tion asso­cia­ted with poststress myocardial stunning of the left ventricle in va­so­di­la­tor stress myocardial perfu­sion SPECT: True marker of se­ve­re ische­mia? J Nucl Cardiol 2005; 12(3): 258–260.

14. Bo­now R. O, Bo­hannon N, Hazzard W. Risk stra­ti­fi­ca­tion in co­ro­na­ry arte­ry di­sea­se and spe­cial po­pu­la­tions. Am J Med 1996; 101(Suppl): 17–22.

15. Kha­lee­li E, Pe­ters SR, Bobrowsky K et al. Dia­be­tes and the asso­cia­ted inci­dence of subcli­ni­cal athe­roscle­ro­sis and co­ro­na­ry arte­ry di­sea­se: impli­ca­tions for ma­na­ge­ment. Am Heart J 2001; 141: 637–644.

16. Kang X, Berman DS, Le­win HC et al. Incre­mental prognostic va­lue of myocardial perfu­sion single pho­ton emission compu­ted to­mography in pa­tients with dia­be­tes melli­tus. Am Heart J 1999; 138: 1025–1032.

17. Nesto RW, Phillips RT, Kett KG et al. Angi­na and exertio­nal myocardial ische­mia in diabe­tic and nondia­be­tic pa­tients: assessment by exerci­se thallium scintigraphy. Ann Intern Med 1988; 108: 170–175.

18. Ha­cha­mo­vitch R, Berman DS, Kiat H et al. Exerci­se myocardial perfu­sion SPECT in pa­tients without known co­ro­na­ry arte­ry di­sea­se: incre­mental prognostic va­lue and use in risk stra­ti­fi­ca­tion. Circu­la­tion 1996; 93: 905–914.

19. Sa­sao H, Na­ka­ta T, Tsu­chi­hashi K et al. Impai­red exerci­se–re­la­ted myocardial upta­ke of techne­tium–99m–tetro­fosmin in re­la­tion to co­ro­na­ry narro­wing and diabe­tic sta­te: Assessment with quanti­ta­ti­ve single pho­ton emission compu­ted to­mography. Jpn Heart J 2001; 42(1): 29–42.

20. Germa­no G. Cli­ni­cal Ga­ted Cardiac SPECT. New York: Fu­tu­ra Pub­li­shing 1999.

21. Germa­no G, Kiat H, Ka­va­nagh et al. Auto­ma­tic quanti­fi­ca­tion of ejection fraction from ga­ted myocardial perfu­sion SPECT. J Nucl Med 1995; 36(11): 2138–2147.

22. Pe­tix NR, Sesti­ni S, Coppo­la A et al. Prognostic Va­lue of Combi­ned Perfu­sion and Function by Stress Techne­tium–99mSesta­mi­bi Ga­ted SPECT Myocardial Perfu­sion Ima­ging in Pa­tients With Suspected or Known Co­ro­na­ry Arte­ry Di­sea­se. Am J of Cardio­lo­gy 2005; 95(11): 1351–1387.

23. Pe­na H, Guilhermi­na G, Ma­cha­do AP et al. Risk factors and co­ro­na­ry arte­ry di­sea­se in myocardial perfu­sion ga­ted. J Nucl Cardiol 2003; Part 2 , 10 (1) PRO­SÍM AU­TO­RA O DO­PL­NĚ­NÍ STRÁN­KO­VÉ­HO ROZ­SA­HU

24. Belch JJF, To­pol EJ, Agnelli G et al. Cri­ti­cal issues in pe­riphe­ral arte­rial di­sea­se de­tection and ma­na­ge­ment: a call to ac­ti­on. Arch Intern Med 2003; 163: 884–892.

25. Giorda­no A, Calcagni ML, Verrillo A et al. Assessment of sympathe­tic innerva­tion of the heart in dia­be­tes melli­tus using ¹²³I–MIBG. Dia­be­tes Nutr Me­tab 2000; 13(6): 350–355.

26. Ma­chac J. Conventio­nal, Me­ta­bo­lic, and Neuroendocri­ne Ima­ging in the Se­lection of Pa­tients for By­pass vs. Transplant Surge­ry. 1 st Virtual Congres of Cardio­lo­gy 2003.PRO­SÍM AU­TO­RA O DO­PL­NĚ­NÍ, KDY SE KONG­RES KO­NAL, EVENT. WE­BO­VÉ STRÁN­KY

27. Bengel FM, Perma­netter B, Unge­rer M et al. Alterna­tion of the sympathe­tic nervous system and me­ta­bo­lic per­for­man­ce of the cardio­myo­pathic heart. Eur J Nucl Med 2002; 29(2): 198–202.

28. Ma­ri­ni C, Giorgetti A, Gi­melli A et al. Extension of myocardial necro­sis diffe­rently affects MIBG re­tention in heart failu­re caused by ischae­mic heart di­sea­se or by di­la­ted cardio­myo­pathy. Eur J Nucl Med 2005; 32(6): 682–688.

29. Scott LA, Kench PL. Cardiac Auto­no­mic Neuro­patjy in the Diabe­tic Pa­tient: Does ¹²³I–MIBG Ima­ging Ha­ve a Ro­le to Play in Early Diagno­sis? J Nucl Med Technol 2004; 32(2): 66–71.

30. To­lar V. Vý­znam vy­šet­řo­vá­ní zdra­vých pro pre­ven­ci. Prakt lék 1936; 16: PRO­SÍM AU­TO­RA O DO­PL­NĚ­NÍ STRÁN­KO­VÉ­HO ROZ­SA­HU

31. Lu­cigna­ni G. Da­ta acqui­si­tion and ana­ly­sis: the strenght of metho­do­lo­gy in nuclear me­di­ci­ne and mo­le­cu­lar ima­ging. Eur J Nucl Med 2006; 33(12): 1513–1516.

32. Lu­cigna­ni G. PET/CT in cardio­lo­gy: an area who­se bounda­ries are still out of sihgt. Eur J Nucl Med 2006; 33(5): 622–623.

33. http://www.mdlinx.com

34. http://www.auntminnie.com

35. http://www.diagnosticimaging.com

36. http://www.medscape.com

37. http://www.docguide.com

38. http://www.csnm.cz